Tonix Pharmaceuticals Holding (TNXP) Amortization of Deferred Charges (2011 - 2012)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Amortization of Deferred Charges came in at -$166.0 in Q4 2012, down 100.31% year-on-year from $53377.0 in Q1 2012, and down 100.08% quarter-over-quarter from $196166.0 in Q1 2012.
Tonix Pharmaceuticals Holding (TNXP) Amortization of Deferred Charges (2011 - 2012) Analysis & Trends
Tonix Pharmaceuticals Holding's Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at -$166.0 for Q4 2012.
- On a quarterly basis, Amortization of Deferred Charges fell 100.31% year-over-year to -$166.0 in Q4 2012; TTM through Sep 2013 was -$166.0, a 100.07% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, changed N/A from the prior year.
- Amortization of Deferred Charges fell to -$166.0 in Q4 2012 per TNXP's latest filing, from $196166.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $196166.0 in Q1 2012 and bottomed at -$166.0 in Q4 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | Tonix Pharmaceuticals Holding | 136.66 Mn | 136.66 Mn | 5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -166.00 |
| Dec 31, 2012 | -166.00 |
| Mar 31, 2012 | 196,166.00 |
| Mar 31, 2012 | 196,166.00 |
| Dec 31, 2011 | 53,377.00 |
| Dec 31, 2011 | 53,377.00 |